Cargando…
Low‐Dose, Contrast‐Enhanced Mammography Compared to Contrast‐Enhanced Breast MRI: A Feasibility Study
Contrast‐enhanced MRI (CE‐MRI) is the most sensitive technique for breast cancer detection. Contrast‐enhanced mammography (CEM) is emerging as a possible alternative to CE‐MRI. PURPOSE: To evaluate the diagnostic performance of a low radiation dose contrast‐enhanced mammography (L‐CEM) in women with...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496227/ https://www.ncbi.nlm.nih.gov/pubmed/32061002 http://dx.doi.org/10.1002/jmri.27079 |
_version_ | 1783583050546806784 |
---|---|
author | Clauser, Paola Baltzer, Pascal A.T. Kapetas, Panagiotis Hoernig, Mathias Weber, Michael Leone, Federica Bernathova, Maria Helbich, Thomas H. |
author_facet | Clauser, Paola Baltzer, Pascal A.T. Kapetas, Panagiotis Hoernig, Mathias Weber, Michael Leone, Federica Bernathova, Maria Helbich, Thomas H. |
author_sort | Clauser, Paola |
collection | PubMed |
description | Contrast‐enhanced MRI (CE‐MRI) is the most sensitive technique for breast cancer detection. Contrast‐enhanced mammography (CEM) is emerging as a possible alternative to CE‐MRI. PURPOSE: To evaluate the diagnostic performance of a low radiation dose contrast‐enhanced mammography (L‐CEM) in women with suspicious findings on conventional imaging compared to CE‐MRI of the breast. STUDY TYPE: Prospective, single center. POPULATION: Women with suspicious findings on mammography, tomosynthesis, or ultrasound, and no contraindications for L‐CEM or CE‐MRI. Eighty women were included. FIELD STRENGTH/SEQUENCE: 1.5 and 3T CE‐MRI, standard protocol for breast, with dedicated coils, according to international guidelines. L‐CEM was performed using a dedicated prototype. ASSESSMENT: Three, off‐site, blinded readers evaluated the images according to the BI‐RADS lexicon in a randomized order, each in two separate reading sessions. Histology served as a gold standard. STATISTICAL TEST: Lesion detection rate, sensitivity, specificity, and negative and positive predictive values (NPV, PPV) were calculated and compared with multivariate statistics. RESULTS: Included were 80 women (mean age, 54.3 years ±11.2 standard deviation) with 93 lesions (32 benign, 61 malignant). The detection rate was significantly higher with CE‐MRI (92.5–94.6%; L‐CEM 79.6–91.4%, P = 0.014). Sensitivity (L‐CEM 65.6–90.2%; CE‐MRI 83.6–93.4%, P = 0.086) and NPV (L‐CEM 59.6–71.4%; CE‐MRI 63.0–76.5%, P = 0.780) did not differ between the modalities. Specificity (L‐CEM 46.9–96.9%; CE‐MRI 37.5–53.1%, P = 0.001) and PPV (L‐CEM 76.4–97.6%; CE‐MRI 73.3–77.3%, P = 0.007) were significantly higher with L‐CEM. Variations between readers were significant for sensitivity and NPV. The accuracy of L‐CEM was as good as CE‐MRI (75.3–76.3% vs. 72.0–75.3%, P = 0.514). DATA CONCLUSION: L‐CEM showed a high sensitivity and accuracy in women with suspicious findings on conventional imaging. Compared to CE‐MRI, L‐CEM has the potential to increase specificity and PPV. L‐CEM might help to reduce false‐positive biopsies while obtaining sensitivity comparable to that of CE‐MRI LEVEL OF EVIDENCE: 1 TECHNICAL EFFICACY STAGE: 2 J. Magn. Reson. Imaging 2020;52:589–595. |
format | Online Article Text |
id | pubmed-7496227 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74962272020-09-25 Low‐Dose, Contrast‐Enhanced Mammography Compared to Contrast‐Enhanced Breast MRI: A Feasibility Study Clauser, Paola Baltzer, Pascal A.T. Kapetas, Panagiotis Hoernig, Mathias Weber, Michael Leone, Federica Bernathova, Maria Helbich, Thomas H. J Magn Reson Imaging Original Research Contrast‐enhanced MRI (CE‐MRI) is the most sensitive technique for breast cancer detection. Contrast‐enhanced mammography (CEM) is emerging as a possible alternative to CE‐MRI. PURPOSE: To evaluate the diagnostic performance of a low radiation dose contrast‐enhanced mammography (L‐CEM) in women with suspicious findings on conventional imaging compared to CE‐MRI of the breast. STUDY TYPE: Prospective, single center. POPULATION: Women with suspicious findings on mammography, tomosynthesis, or ultrasound, and no contraindications for L‐CEM or CE‐MRI. Eighty women were included. FIELD STRENGTH/SEQUENCE: 1.5 and 3T CE‐MRI, standard protocol for breast, with dedicated coils, according to international guidelines. L‐CEM was performed using a dedicated prototype. ASSESSMENT: Three, off‐site, blinded readers evaluated the images according to the BI‐RADS lexicon in a randomized order, each in two separate reading sessions. Histology served as a gold standard. STATISTICAL TEST: Lesion detection rate, sensitivity, specificity, and negative and positive predictive values (NPV, PPV) were calculated and compared with multivariate statistics. RESULTS: Included were 80 women (mean age, 54.3 years ±11.2 standard deviation) with 93 lesions (32 benign, 61 malignant). The detection rate was significantly higher with CE‐MRI (92.5–94.6%; L‐CEM 79.6–91.4%, P = 0.014). Sensitivity (L‐CEM 65.6–90.2%; CE‐MRI 83.6–93.4%, P = 0.086) and NPV (L‐CEM 59.6–71.4%; CE‐MRI 63.0–76.5%, P = 0.780) did not differ between the modalities. Specificity (L‐CEM 46.9–96.9%; CE‐MRI 37.5–53.1%, P = 0.001) and PPV (L‐CEM 76.4–97.6%; CE‐MRI 73.3–77.3%, P = 0.007) were significantly higher with L‐CEM. Variations between readers were significant for sensitivity and NPV. The accuracy of L‐CEM was as good as CE‐MRI (75.3–76.3% vs. 72.0–75.3%, P = 0.514). DATA CONCLUSION: L‐CEM showed a high sensitivity and accuracy in women with suspicious findings on conventional imaging. Compared to CE‐MRI, L‐CEM has the potential to increase specificity and PPV. L‐CEM might help to reduce false‐positive biopsies while obtaining sensitivity comparable to that of CE‐MRI LEVEL OF EVIDENCE: 1 TECHNICAL EFFICACY STAGE: 2 J. Magn. Reson. Imaging 2020;52:589–595. John Wiley & Sons, Inc. 2020-02-14 2020-08 /pmc/articles/PMC7496227/ /pubmed/32061002 http://dx.doi.org/10.1002/jmri.27079 Text en © 2020 The Authors. Journal of Magnetic Resonance Imaging published by Wiley Periodicals, Inc. on behalf of International Society for Magnetic Resonance in Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Clauser, Paola Baltzer, Pascal A.T. Kapetas, Panagiotis Hoernig, Mathias Weber, Michael Leone, Federica Bernathova, Maria Helbich, Thomas H. Low‐Dose, Contrast‐Enhanced Mammography Compared to Contrast‐Enhanced Breast MRI: A Feasibility Study |
title | Low‐Dose, Contrast‐Enhanced Mammography Compared to Contrast‐Enhanced Breast MRI: A Feasibility Study |
title_full | Low‐Dose, Contrast‐Enhanced Mammography Compared to Contrast‐Enhanced Breast MRI: A Feasibility Study |
title_fullStr | Low‐Dose, Contrast‐Enhanced Mammography Compared to Contrast‐Enhanced Breast MRI: A Feasibility Study |
title_full_unstemmed | Low‐Dose, Contrast‐Enhanced Mammography Compared to Contrast‐Enhanced Breast MRI: A Feasibility Study |
title_short | Low‐Dose, Contrast‐Enhanced Mammography Compared to Contrast‐Enhanced Breast MRI: A Feasibility Study |
title_sort | low‐dose, contrast‐enhanced mammography compared to contrast‐enhanced breast mri: a feasibility study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496227/ https://www.ncbi.nlm.nih.gov/pubmed/32061002 http://dx.doi.org/10.1002/jmri.27079 |
work_keys_str_mv | AT clauserpaola lowdosecontrastenhancedmammographycomparedtocontrastenhancedbreastmriafeasibilitystudy AT baltzerpascalat lowdosecontrastenhancedmammographycomparedtocontrastenhancedbreastmriafeasibilitystudy AT kapetaspanagiotis lowdosecontrastenhancedmammographycomparedtocontrastenhancedbreastmriafeasibilitystudy AT hoernigmathias lowdosecontrastenhancedmammographycomparedtocontrastenhancedbreastmriafeasibilitystudy AT webermichael lowdosecontrastenhancedmammographycomparedtocontrastenhancedbreastmriafeasibilitystudy AT leonefederica lowdosecontrastenhancedmammographycomparedtocontrastenhancedbreastmriafeasibilitystudy AT bernathovamaria lowdosecontrastenhancedmammographycomparedtocontrastenhancedbreastmriafeasibilitystudy AT helbichthomash lowdosecontrastenhancedmammographycomparedtocontrastenhancedbreastmriafeasibilitystudy |